These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6413397)

  • 41. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical considerations and management of rheumatoid arthritis.
    Ferlic DC; Smyth CJ; Clayton ML
    J Hand Surg Am; 1983 Sep; 8(5 Pt 2):662-6. PubMed ID: 6415155
    [No Abstract]   [Full Text] [Related]  

  • 44. Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis.
    Arrigoni-Martelld E; Bramm E
    Agents Actions; 1975 Aug; 5(3):264-7. PubMed ID: 829840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Disease-modifying" drugs in rheumatoid arthritis.
    Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
    [No Abstract]   [Full Text] [Related]  

  • 46. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of rheumatoid factor in vitro: implications for the pathogenesis of rheumatoid arthritis.
    Olsen NJ; Jasin HE
    Semin Arthritis Rheum; 1985 Nov; 15(2):146-56. PubMed ID: 2999987
    [No Abstract]   [Full Text] [Related]  

  • 49. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined?
    Bird HA
    Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869
    [No Abstract]   [Full Text] [Related]  

  • 50. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E; Jellum E; Aaseth J
    Rheumatol Rehabil; 1978; Suppl():105-8. PubMed ID: 103179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E; Munthe E; Guldal G; Aaseth J
    Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Rheumatoid arthritis. Considerations on a rational therapeutic strategy].
    Tarocco RP; Faro G; Michelotti A; Sargiotto A
    Minerva Med; 1984 Feb; 75(8):363-74. PubMed ID: 6369174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Appraisal of long-term therapy of inflammatory rheumatic diseases with tauredon, indomethacin, brufen and volon].
    Banciu M; Seceleanu A; Tiroch L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):541-8. PubMed ID: 44757
    [No Abstract]   [Full Text] [Related]  

  • 54. Disease-modifying drug therapy in rheumatoid arthritis.
    Pinals RS
    Clin Ther; 1986; 9(1):2-7. PubMed ID: 3815458
    [No Abstract]   [Full Text] [Related]  

  • 55. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis.
    Häntzschel H; Otto W; Arnold S; Seidel W; Krüger W; Winiecki P; Bird HA; Dixon JS; Astbury G; Wright V
    Clin Rheumatol; 1988 Jun; 7(2):181-7. PubMed ID: 3138060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 59. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 60. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.